Phillip Lieberman, MD

Dr. Phillip Lieberman | Allergist

ARTICLES

ABSTRACTS

1. Lieberman P, Petersen V, Ricks J, Patterson R, Chakrin L, and Wardell JR. Effect of Route of
Administration and Type of Antigen on Antibody in the Canine Tracheal Pouch. Presented at FASEB, American Association of Immunologists, (ABST) April 1971.

2. Lieberman P, Berlin B, and Patterson R. Respiratory Immune Response of Dogs to Influenza Virus. Presented at American Association of Microbiologists, (ABST) May 1971.

3. Patterson J, Harwell WB, Lieberman P, and Beachey E. Platelet Aggregation in Atopic and Normal Subjects. Presented at the American Academy of Allergy, (ABST) February 1973.
Journal Allergy and Clinical Immunology, 49:87, (ABST) 1972.

4. Lieberman P, Patterson J, Harwell WB, and Beachey E. Platelet Aggregation in Atopic and Normal Subjects. Presented at Southern Section of AFCR, (ABST) January 1973.

5. Metcalfe D, Lieberman P, and Robinson H. Urinary Cyclic AMP in Asthmatics. Presented at
Southern Section of AFCR, (ABST) January 1973.

6. Mallette J, and Lieberman P. The Effect of the Establishment of a Fulltime Allergy-Immunology
Service on the Care of Asthmatics in a University-City Hospital. Presented at American Academy of Allergy, (ABST) January 1974. Journal Allergy and Clinical Immunology, 53:78, (ABST 33) 1974.

7. Lieberman P, Crawford L, Bjelland J, and Connell B. Controlled Study of the Cytotoxic Food Test.
Presented at American Academy of Allergy, (ABST) January 1974. Journal Allergy and Clinical Immunology, 53:89, (ABST 61) 1974.

8. Lamkin N Jr, Lieberman P, Shereff R, Rosenberg EW, and Robinson H. Effect of Beta Adrenergic
Stimulation and Blockade on Cutaneous Reactivity to Histamine. Presented at American Academy of Allergy, February 1975. Journal Allergy and Clinical Immunology, (ABST 109) 55:113, 1975.

9. Burson Robert A, Thomas J Ward, Lieberman Phil, and Neely Charles L. Low Dose Dialyzable
Transfer Factor in the Treatment of Selective Malignancies. Journal of the Tennessee Medical Association, (ABST 2) 68:8, 656-657, 1975.

10. Srouji Antoine, Lieberman P, McLeod Robert, Lamkin N Jr, and Horton Glenn. Isolation of a
Major Allergen from Bermuda Grass Pollen. Presented at American Academy of Allergy, (ABST 116) 57:237, 1976.

11. Lieberman P, Mallette James E Jr, and Rice Muriel. Studies of Urticaria Using the Clq Precipitin
Test. Presented at American Academy of Allergy, March 1976. Journal Allergy and Clinical Immunology, (ABST 107) 56:233, 1976.

12. Crawford LV, Lieberman P, Harfi HA, Hale R, Nelson H, Selner J, Wittig H, Postman M and
Zietz H. A Double Blind Study of Subcutaneous Food Testing Sponsored by the Food Committee of the American Academy of Allergy. Presented at American Academy of Allergy, March 1976.
Journal Allergy and Clinical Immunology, (ABST 114) 57:236, 1976.

13. Daman Lauren, Ganier Mitchell, Lieberman Phil, and Hashimoto Ken. Localized Heat Urticaria -
Pathophysiologic Studies. Presented at The American Congress of Allergy and Immunology, New York, NY, March 1977 (ABST 216). Library of Congress Cat #77-79345, Washington, D.C. 20540. Annals of Allergy, 39:1, 78, 1977.

14. Srouji Antoine H, Lieberman Phil, and Hill Robert J. Some Properties of the Major Allergen of
Bermuda Grass Pollen (BgP). Presented at The American Congress of Allergy and Immunology, New York, NY, March 1977 (ABST 422). Library of Congress Cat #77-79345, Washington, D.C. 20540. Annals of Allergy, 38:4, 305, 1977.

15. Ganier Mitchell, Lieberman Phil, and George Steve. Comparison of Skin Testing with Stock Mixture
(SM) and Individual (I) Antigens. Presented at The American Congress of Allergy and Immunology. New York, NY, March 1977 (ABST 105). Library of Congress Cat #77-79345, Washington, D.C. 20540. Annals of Allergy, 38:5, 385, 1977.

16. Siegle Robert L, and Lieberman Phil. The In Vitro White Cell Response of Atopics to Iodinated
Contrast Material. Presented at the Sixty-Third Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago, IL, November 27-December 2, 1977.

17. Lieberman Phil, and Siegle Robert. Studies of Complement (C) in Acute Reactions to Iodinated
Contrast Material (ICM). Presented at the American Academy of Allergy, Phoenix, AZ, February 1978. Journal Allergy and Clinical Immunology, (ABST 58) 61:145, 1978.

18. Ganier Mitchell, and Lieberman Phil. Pancreatic Enzyme (PE) Induced Asthma. Presented at the
American Academy of Allergy, Phoenix, AZ, March 1, 1978. Journal Allergy and Clinical Immunology, (ABST 219) 61:194, 1978.

19. Lieberman Phil, and Taylor WW Jr. Recurrent Idiopathic Anaphylaxis. Presented at the American
Academy of Allergy, New Orleans, LA, March 27, 1979. Journal Allergy and Clinical Immunology, (ABST 134) 63:74, 1979.

20. Taylor WW, Ganier Mitchell, Lieberman Phil, Fink Jordan, and Lockwood DG. Humidifier Lung:
An Outbreak in Office Workers. Presented at American Academy of Allergy, New Orleans, LA, March 28, 1979. Journal Allergy and Clinical Immunology, (ABST 244) 63:205, 1979.

21. Hendrix S, Zeiss C, Suszko I, Lieberman P, McQueen R, Miller M, Slavin R, Sheffer A II, and
Patterson R. Polymerized Ragweed Allergens: Multi-Institutional Study of the Safety and Efficacy of an Improved Form of Immunotherapy, (ABST 4) 65:164, 1980.

22. Greenberger P, Patterson R, Stevenson D, Simon R, and Lieberman P. Pre-Treatment of High-Risk
Patients Requiring Radiographic Contrast Media. Journal Allergy and Clinical Immunology, (ABST 184) 65:220, 1980.

23. Davis PB, and Lieberman P. Normal Beta-Adrenergic Receptors in Lymphocytes from Subjects
with Asthma. American Review Resp Disease, 123(4):214, 1981. Presented at American Thoracic Society, Detroit, MI, May 12, 1981.

24. Blaiss M, Herrod H, Crawford L, and Lieberman P. Beclomethasone Dipropionate Aerosol (BDP):
Hematological and Immunological Effects. Presented at the American Academy of Allergy, San Francisco, CA, (ABST 19) March 1981.

25. Chiu CH, Cazin J, Kuo CY, Roger G, Chung TW, Lieberman P, Crawford L, and Yoo TJ. Allergic
Properties of Different Sources of Alternaria Antigens. Presented at the American Academy of Allergy, San Francisco, CA, (ABST 272) March 1981.

26. Rice M, Lieberman P, Siegle R, and Mason J. In Vitro Studies of Reactions to Radiocontrast Agents
(ICM). Presented at American Academy of Allergy, San Francisco, CA, (ABST 282) March 1981.

27. McKenna W, Lieberman P, Erffmeyer J, and Treadwell G. Dose Dependent Efficacy of Fluocortin
Butyl (FCB) in Therapy of Perennial Rhinitis. Presented at the American Academy of Allergy, Montreal, Canada, (ABST 246) March 1982. Journal Allergy and Clinical Immunology, (ABST 246) 69 (1, Part 2):154, 1982.

28. Lieberman P. Anaphylactoid Reactions to Radiocontrast Material. In: Proceedings of XI International
Congress of Allergology and Clinical Immunology. Ker JW and Ganderton MA (eds.). McMillan Press Ltd, London and Basingstoke (1983), page 61. Presented London, England, October 1982.

29. Siegle RL, Lieberman P, and Rice MC. In Vitro Complement Consumption by Contrast Materials
and Analogues: Reactors versus Non-Reactors. Presented at the 30th Annual Meeting of the Association of University Radiologists, Baltimore, MD, April 1982.

30. Dyer J, Merlin S, Greenhill A, Shelton A, Treadwell G, Lieberman P, and Kaliner M. Urine
Histamine After Intravenous Contrast Studies. Presented at American Academy of Allergy & Clinical Immunology, Hollywood, FL, March 1983 (ABST 237). Journal Allergy and Clinical Immunology, 71(1, Part 2):148, 1983.

31. Grant W, Orman S, Kuo CY, Budd T, Taylor WW, Lieberman P, and Yoo TJ. Study of Basic Protein
Allergens in Alternaria Allergy. Presented at the American Academy of Allergy and Clinical Immunology, Hollywood, FL, March 1983 (ABST 30). Journal Allergy and Clinical Immunology, 71(1, Part 2):96, 1983.

32. Irwin R, Lieberman P, Kaplan R, Kaliner M, Treadwell G, and Yoo T. Mediator Release in Local
Heat Urticaria (LHU): Protection with Combined H-1 and H-2 Antagonists. Presented at the American Academy of Allergy and Clinical Immunology, Chicago, IL, March 1984 (ABST 291). Journal Allergy and Clinical Immunology, 73(1, Part 2):181, 1984.

33. Younger RE, Herrod HG, Lieberman PL, and Crawford LV. Production of Histamine Release
Enhancing Factor (HREF) by PHA Stimulated Mononuclear Cells. Presented at the American Academy of Allergy and Clinical Immunology, New York, NY, March 1985 (ABST 20). Journal Allergy and Clinical Immunology, 75 (1 Part 2):109, 1984.

34. Herrod HG, Younger RE, Lieberman PL, Trouy RL, and Crawford LV. Characteristics of Basophil Histamine Release (BHR) after Exposure to the Radiocontrast Agent Diatrizoate (DT). Presented at the American Academy of Allergy and Clinical Immunology, New York, NY, March 1985 (ABST 359). Journal Allergy and Clinical Immunology, 75(1 Part 2):194, 1984.

35. Treadwell G, Lieberman P, Herrod H, and Crawford L. Standard RAST (R) as a Predictor for Initial
Dose (InDo) of Immunotherapy (IT). Presented at the XII International Congress of Allergology and Clinical Immunology, October 1985, Washington, D.C. (ABST 630). Annals of Allergy, Part II, 55:383, 1985.

36. Erffmeyer JE, Siegle RL, Lieberman P. Allergy Grand Rounds. Anaphylactoid Reactions to
Radiocontrast Material. J Allergy Clin Immunol 75(3):401-410, March 1985.

37. Lieberman P, Herrod H, Younger R, Crawford L, Gross S, and Valenske W. Effect of Corticosteroids
(C) on the Synthesis of Histamine Release Enhancing Factor (HREF). Presented at the American Academy of Allergy and Immunology, New Orleans, LA, March 1986 (ABST 45). Journal Allergy and Clinical Immunology, 77(No. 1, Part 2):132, 1986.

38. Younger RE, Herrod HG, Lieberman P, and Crawford LV. Characterization of Mononuclear Cell
Derived Histamine Release Enhancing Factor (HREF) Activity. Presented at the American Academy of Allergy and Immunology, New Orleans, LA, March 1986 (ABST 44). Journal Allergy and Clinical Immunology, 77(No. 1, Part 2):131, 1986.

39. Cohen R, Grant B, Lieberman P, Potter W, Golden S, Crawford L, Herrod H, and Yoo T. The Use of
Methacholine Inhalation, Methacholine Skin Testing, Distilled Water Inhalation Challenge & Eosinophil Counts in the Evaluation of Patients Presenting with Cough and/or Nonwheezing Dyspnea. Presented at the American Academy of Allergy and Clinical Immunology, Chicago, IL, March 1984 (ABST 66). Journal Allergy and Clinical Immunology, 73(1, Part 2):125, 1984; and Respiratory Diseases Digest, 3:7-8, 1987.

40. Siegle RL, and Lieberman P. Histamine Release, Complement Activation, and Immune Mechanisms
Associated with the Use of Iodinated Contrast Material. In Contrast Media: Biologic Effects and Clinical Application, Vol. I. Parvez Zaheer, R. Moncada, and M. Sovak (eds.). CRC Press, Boca Raton, FL, pp. 151-162, 1987.

41. Wolf B, and Lieberman P. Retrospective Review of 89 Patients with Anaphylaxis. Presented at the
American Academy of Allergy and Immunology, Anaheim, CA, 1988. Journal Allergy and Clinical Immunology, (ABST) 81(1):238, 1988.

42. Allen M, Arlian L, Bernstein L, Friedman S, Grant A, Lieberman P, Lopez M, Metzger J, Schott M,
Schatz, Spector S, and Wasserman S. Prevalence of Dust Mites in Homes of Asthmatics in Several U.S. Geographical Regions. Journal Allergy and Clinical Immunology, (ABST) 81(1):270, 1988.

43. Wolf B, and Lieberman P. Analysis of 200 Cases of Anaphylaxis. Allergy Suppl 7V43:1988 and
presented at the Annual Meeting of the European Academy of Allergology and Clinical Immunology, Copenhagen, Denmark, June 18-22, 1988. Allergy Suppl 7, Volume 43, 1988.

44. Marshall G, and Lieberman P. Analysis of Three Pre-Treatment Procedures to Prevent Anaphylactoid
Reactions to Radiocontrast (RCM) in Previous Reactors (R). Journal Allergy and Clinical Immunology, 83(1):254, 1989 (ABST 331). Presented at the American Academy of Allergy and Immunology, San Antonio, TX, March 1989.

45. Fox R, Lockey R, Altman L, Lieberman P, Wasserman S, Whitcomb N, Carmichael CA, Altman R,
Love S, and Samuels L. Cetirizine in the Treatment of Allergic Rhinitis, A Comparison with Terfenadine. Journal Allergy and Clinical Immunology, 83(1):307, 1989 (ABST 542). Presented at the American Academy of Allergy and Immunology, San Antonio, TX, March 1989.

46. Lieberman P, et al. Comparison of Extended-Release Albuterol (Volmax, V) vs. Theophylline (T)
vs. Placebo (P) in Adults with Chronic Asthma. Annals of Allergy, submitted for publication, 1989.

47. Kaplan AP, Anderson JA, Valentine MD, Lockey RF, Pierson WE, Zewiman B, Kaliner MA,
Lichtenstein LM, Lieberman PL, Settipane GA, et al. Beta-adrenergic Blockers, Immunotherapy,
and Skin Testing. Presented at the American Academy of Allergy and Immunology. J Allergy Clin
Immunol 84(1):129-130, July 1989.

48. Orgel HA, Meltzer EO, Bierman CW, Bronsky E, Connell JT, Lieberman PL, et al. Intranasal
Fluocortin Butyl in Patients with Perennial Rhinitis, A 12-Month Efficacy and Safety Study Including Nasal Biopsy. Journal Allergy and Clinical Immunology, submitted for publication, 1989.

49. Donohue JF, Aaronson DW, Dockhorn RJ, Johnson RL, Lieberman P, Schaberg AE, and
Cocchetto DM. Comparison of Extended-Release Albuterol (Volmax, V) vs. Theophylline (T) vs. Placebo (P) in Adults with Chronic Asthma. Submitted to the American College of Allergy and Immunology meeting, November 1989.

50. Kim HW, Yoo TJ, and Lieberman P. Protamine Hypersensitivity Presenting as an Insulin Reaction.
Journal Allergy and Clinical Immunology, (ABST 546) 87:276, January 1991.

51. Babe KS, Zebrowski M, Lieberman P, and Kim R. Successful Hypothermic Cardiopulmonary Bypass
in a Patient with Primary Cold Urticaria. Annals of Allergy, submitted for publication, 1991.

52. Kemp S, Lieberman P, and Wolf B. Review of 267 Cases of Anaphylaxis in Clinical Practice.
Journal Allergy and Clinical Immunology, (ABST 50)91(No. 1, Part 2), p. 513, January 1993.

53. Shield S, Lieberman P, and Herrod H. Effects of Pityrosporum Ovale and Iophor on In Vitro IgE
Production in Patients with Atopic Dermatitis. Journal Allergy and Clinical Immunology, (ABST 417) 91(No. 1, Part 2) p. 245, January 1993.

54. Kemp S, Lockey R, Wolf B and Lieberman P. Anaphylaxis: A Review of 266 Cases. In: Allergy
Proceedings, Vol. 16, p. 311, November-December 1995.

55. Yates S, Carter P, Heinly T and Lieberman P. Accelerated Irreversible Decline in Lung Function in
Asthmatics. In: Journal of Allergy and Clinical Immunology, Vol 99, No. 1, Part 2, p. S417 (abstract 1695), January 1997.

56. Kagy LM, Blaiss MS and Lieberman P. Clinical Profile of 380 Cases of Anaphylaxis. American College
of Allergy, Asthma, and Immunology Meeting (abstract), San Diego, November 1997.

57. Stabile K, Blaiss MS, McKown KM, and Lieberman P. Atypical Lupus Associated with Parvovirus
Infection Presenting as Chronic Urticaria. American College of Allergy, Asthma, and Immunology
Meeting (abstract), San Diego, November 1997.

58. Heinly T, Lieberman P, and Blaiss MS. Superior Vena Cava Syndrome Mimicking Angioedema.
American College of Allergy, Asthma, and Immunology Meeting (abstract), San Diego, November
1997.

59. Kagy LM, Heinly T, Rady R, Blaiss M and Lieberman P. Cotton Seed Oil Anaphylaxis Masquerading as
Testosterone Reaction. In: Journal of Allergy and Clinical Immunology, Vol 101, p.S32, January 1998.

60. Heinly TL, Lieberman P, Blaiss MS. Incidence and Evaluation of Local Anesthetic Drug Reactions Over
a 10 Year Period. In: Journal of Allergy and Clinical Immunology, (ABST 219), Vol 101, p. S51,
January 1998.

61. Kagy LM, Blaiss MS and Lieberman P. Clinical Profile of 380 Cases of Anaphylaxis. Annals of Allergy,
Asthma and Immunology, Vol 80, p.81 (abstr 12), January 1998.

62. Stabile KA, Blaiss MS, McKown KM and Lieberman P. Atypical Lupus Associated with Parvovirus
Infection Presenting as Chronic Urticaria. Annals of Allergy, Asthma and Immunology, Vol 80, p. 85
(abstr 28), January 1998.

63. Heinly TL, Lieberman P, and Blaiss MS. Superior Vena Cava Syndrome Mimicking Angioedema.
Annals of Allergy, Asthma and Immunology, Vol 80, p. 86 (abstr 29), January 1998.

64. Heinly TL, Lieberman P, Blaiss MS. Incidence and Evaluation of Local Anesthetic Drug Reactions Over
a 10 Year Period. American Academy of Allergy, Asthma, and Immunology Meeting (abstract),
Washington, D.C., March 1998.

65. Kagy LM, Heinly T, Rady R, Blaiss M and Lieberman P. Cotton Seed Oil Anaphylaxis Masquerading as
Testosterone Reaction. American Academy of Allergy, Asthma, and Immunology Meeting (abstract),
Washington, D.C., March 1998.

66. Heinly T, Lieberman P, Lewis M, and Blaiss M. Ischemic Bowel Disease Secondary to Oral
Contraceptives Masquerading as Shellfish Allergy. American College of Allergy, Asthma &
Immunology Meeting, Philadelphia, November 1998.

67. Berger WE, Fineman SM, Lieberman P. Double-Blind Trials of Astelin (azelastine) Nasal Spray
Monotherapy Versus Combination Therapy with Claritin Plus (+) Beconase AQ in Patients With
Seasonal Allergic Rhinitis (SAR). Journal of Allergy and Clinical Immunology, S252 (abstract #965), 1999.

68. Banov C, LaForce C, Lieberman P. Double-blind trial of Astelin nasal spray in the treatment of
vasomotor rhinitis. Annals of Allergy, Asthma Immunol 84:138, 2000 (abstract).

69. Coghlan-Johnston M and Lieberman P. Demographic and Clinical Characteristics of Anaphylaxis.
Journal of Allergy and Clinical Immunology, 107(2):S57 (abstract), 2001.

70. Lieberman P, Kaliner M, and Wheeler WJ. Open-Label Evaluation of Azelastine Nasal Spray in Patients With Seasonal Allergic Rhinitis and Nonallergic Vasomotor Rhinitis. Presented at the annual meeting of the American College of Allergy, Asthma, and Immunology, New Orleans, LA, November 7-12, 2003.

71. Lieberman P. A Study to Determine if Rhinitis Sufferers Understand What is Meant by Perennial
Non-Allergic Rhinitis. Journal of Allergy and Clinical Immunology, Volume 113(2):S27 February 2004.

72. Webb L, Green E, and Lieberman P. Anaphylaxis: A Review of 593 Cases. Journal of Allergy and
Clinical Immunology, Volume 113(2):S240 February 2004.

73. Varghese M, Lieberman P, Treadwell G, Blaiss M, and Wan J. Omalizumab (O) Administration Reduces Symptom Scores, Medication Use, and Markedly Diminishes Skin Tests (ST) Reactivity. Annals of Allergy, Asthma, and Immunology 2005; 94(1):110 (abstract 39A).

74. Reed J, Yedulapuram M, Lieberman P, and Fitzpatrick E. Differences in Cytokine Production Between Idiopathic Anaphylaxis (IA) Subjects and Controls. Journal of Allergy and Clinical Immunology, Volume 117, page S305 (abstract), 2006.

75. Varghese M and Lieberman P. Factors Affecting the Use of Automatic Epinephrine Injectors. Journal of Allergy and Clinical Immunology, Volume 117, page S305 (abstract), 2006.

76. CA Camargo Jr., S Clark, MS Kaplan, P Lieberman, RA Wood. Regional Differences in EpiPen Prescriptions in the United States. Journal of Allergy and Clinical Immunology, Volume 117, page S139 (abstract), 2006.

77. Varghese M and Lieberman P. A Comparison of Nasal Smear Eosinophil Count via Blow Technique versus the Nasal Scrape Method. Journal of Allergy, Asthma, and Clinical Immunology, Volume 119, page S221 (abstract 870), January 2007.

78. Beaty AD, Lieberman PL, and Slavin RG. Seasonal Allergy and Risk of Adverse Reactions to
Radiocontrast Media: Are Physicians Unwittingly Propagating a Medical Myth? Journal of Allergy, Asthma, and Clinical Immunology, Volume 119, page S149 (abstract 585), January 2007.

79. Camargo CA Jr., Clark S, Pearson JF, Kaplan MS, Lieberman P, Wood RA. Latitude, UVD exposure, and EpiPen prescriptions in 38 urban areas (abstract). Journal of Allergy, Asthma, and Clinical
Immunology, February 2009; 123(2):S109.

80. Farooqui N, Kahn B, Wan J, and Lieberman P. Blood eosinophils as markers of inflammation in asthma. Annals of Allergy, Asthma, and Immunology, November 2009; 103(5):A56 (supplement 3).

BOOK CHAPTERS, BOOKS AND REVIEWS

1. Lieberman P. Ocular and Otic Manifestations of Allergy. R. Patterson (ed.). Allergic Diseases, J. B. Lippincott Co., Philadelphia, New York, Toronto. November 1971.

2. Lieberman P. Corticosteroids in the Treatment of Allergic Diseases. R. Patterson (ed.). Allergic Diseases, J. B. Lippincott Co., Philadelphia, New York, Toronto, pp 575-589, November 1971.

3. Lieberman P, and Patterson R. Immunotherapy for Atopic Diseases. G. Stollerman (ed.). Reprinted from Advances in Internal Medicine, Yearbook Medical Publishers, 19:391-411, 1974.

4. Lieberman P. Insulin Therapy in Patients with Systemic Insulin Allergy. Guidelines to Metabolic Therapy (Upjohn) 4(4):Winter, 1975.

5. Lieberman P. Intrinsic Asthma. Journal of Tennessee Medical Association, 69:5, 334, 1976.

6. Lieberman P. Reaginic Antibodies and the RAST Test, Chapter 9, pp. 226-262, 1977.

7. Lieberman P. IgE and the Radioallergosorbent Test. Lloyd V. Crawford (ed.). Pediatric Allergic Diseases. Focus on Clinical Diagnosis. Medical Examination Publishing Company, Inc., Flushing, NY 1977.

8. Patterson R, Lieberman P, Irons J, Pruzansky JJ, Melam H, Metzger J, and Zeiss CR. Immunotherapy. Elliott Middleton, Jr., Charles E. Reed, and Elliott F. Ellis (eds.). Allergy: Principles and Practice, Mosby Times Mirror, St. Louis, MO, 49:877-898, 1978.

9. Lieberman P, and Wood TO. Allergy and Immunology of Eye Disease. In: Allergy and Clinical Immunology. Lockey RF (ed.), Medical Examination Publishing Company, Flushing, NY, p. 457, 1979.

10. Lieberman P, and Taylor WW Jr. Corticosteroids in the Treatment of Allergic Diseases. R. Patterson (ed.). Allergic Diseases: Diagnosis and Management. 2nd Edition. J. B. Lippincott Company, Philadelphia, PA, 24:654-670, 1980.

11. Lieberman Phil, Crawford Lloyd V, and Drewry Richard. Allergic Diseases of the Eye and Ear.
R. Patterson (ed.). Allergic Diseases: Diagnosis and Management. 2nd Edition. J. B. Lippincott Company, Philadelphia, PA, 340-367, 1980.

12. Lieberman P. Anaphylaxis and Anaphylactoid Reactions. Current Views in Allergy and Immunology. Atlanta, Georgia. (By Invitation). Vol. 1, Program 1, Chapter 5, 121-141, January 1980.

13. Lieberman PL. Use of Corticosteroids in Obstructive Airway Disease. Charles E. Kossman (ed.). Medical Grand Rounds. Journal of the Tennessee Medical Association, 73:355-362, 1980.

14. Lieberman P. Anaphylaxis and Anaphylactoid Reactions. John A. Spittel, Jr. (ed.). Clinical Medicine. Harper & Row, Hagerstown, MD, (By Invitation), Chapter 4, 1981.

15. Erffmeyer John E, and Lieberman P. Management of Penicillin Allergy in Patients with Bacterial Endocarditis. In: Treatment of Infective Endocarditis. A. Bisno (ed.)., Grune & Stratton, Inc., New York, NY, pp 209-233, 1981.

16. Lieberman P. Anaphylaxis and Serum Sickness. In: Current Therapy Thirty Third Edition. Conn HF (ed.). W. B. Saunders Company, New York, NY, pp. 625-630, 1981.

17. Lieberman P, and Crawford L. Management of the Allergic Patient. A Text for the Primary Care Physician. Appleton-Century-Crofts, New York, NY 1981.

18. Lieberman P. Glucocorticosteroids Therapy of Allergic Diseases. In: Primer on Immunologic and Allergic Diseases. John Salvaggio (ed.), JAMA 248:2605-2607, 1982.

19. Lieberman P. Anaphylactoid Reactions to Radiocontrast Material. In: Proceedings of Invited Symposia, XI International Congress of Allergology and Clinical Immunology. Kerr JW, and Ganderton MA (eds.). The Macmillan Press Limited, London and Basingstoke, pp. 61-66, 1983.

20. Lieberman P, and Treadwell G. Anaphylaxis and Serum Sickness. In: Current Emergency Therapy. Edlich RF, and Spyker DA (eds.). Appleton-Century-Crofts, pp. 503-508, 1984.

21. Lieberman P, Crawford L, Drewry RD Jr, and Tuberville A. Allergic Diseases in the Eye and Ear. In: Allergic Diseases Diagnosis and Management. 3rd Edition , Roy Patterson (ed.). J. B. Lippincott Company, Philadelphia, PA , Chapter 11:275-315, 1985.

22. Lieberman P, and Erffmeyer JE. Corticosteroids in the Treatment of Allergic Diseases. In: Allergic Diseases Diagnosis and Management. 3rd Edition, Roy Patterson (ed.). J. B. Lippincott Company, Philadelphia, PA 1985.

23. Lieberman P, Siegle RL, and Treadwell G. Radiocontrast Reactions. In: Clinical Reviews in Allergy. 4(2):229-245, 1986.

24. Lieberman PL. (Topic editor) Hypersensitivity Reactions to Drugs. Clinical Reviews in Allergy. 4(2):141-245, 1986.

25. Lieberman P, Erffmeyer J, and Treadwell G. Drug Reactions. In: Principles of Immunology and Allergy. Lockey RF, and Bukantz S (eds.). W. B. Saunders Company, Philadelphia, PA, pp. 111-137, 1987.

26. Lieberman P, and Lockey R. Drug Allergy. In Allergy: An International Textbook. MH Lessof,
EH Lee, and DM Kemeny (eds.). John Wiley & Sons, Chichester, NY, Brisbane, Toronto, Singapore, pp. 381-409, 1987.

27. Lieberman P. Differential Diagnosis and Treatment of Allergic Diseases of the Eye. In: Internal Medicine for the Specialist. 8(1):200-213, 1987.

28. Lieberman PL MD. Allergic Reactions to Insulin. New Horizons in Allergy and Pulmonary Medicine. V (2): by invitation, 1987.

29. Lieberman P. Rhinitis: Allergic and Nonallergic. Hospital Practice, 23(6):117-145, June 15, 1988.

30. Lieberman P. Clinical Conference: When Rhinitis is More than a Common Cold. Respiratory World, 1(11):3, (November) 1988.

31. Lieberman P. Anaphylaxis and Anaphylactoid Reactions. The Allergy and Asthma Advance, pp 4-6, Jan/Feb:4-6, 1989.

32. Lieberman P. The Use of Antihistamines in the Prevention and Treatment of Anaphylaxis and Anaphylactoid Reactions. Journal of Allergy and Clinical Immunology. 86(4 Pt 2)(S):684-686, 1990.

33. Lieberman P. Anaphylactoid Reactions to Radiocontrast Material. Clinical Reviews in Allergy. Vervloet, D (ed.), The Humana Press, Clifton, NJ, 9(3,4):319-338, Fall-Winter, 1991.

34. Lieberman P. Difficult Allergic Drug Reactions. Immunology and Allergy Clinics of North America. Kemp (ed.), W. B. Saunders Company 11 (1), pp. 213-231, February 1991.

35. Lieberman P. Asthma as an Inflammatory Disease. In: Internal Medicine for the Specialist. 12(6): 18-31, June 1991.

36. Lieberman P. Anaphylactoid Reactions to Radiocontrast Material RCM). Annals of Allergy, 67(2) 91-102, 1991.

37. Marshall G, and Lieberman P. Allergic Rhinitis. Medicine for the Practicing Physician. 3rd edition, J. Willis Hurst (ed.), Butterworth Heinemann, 1992.

38. Lieberman P, and Crawford L. Allergic Diseases of the Eye and Ear. Allergic Diseases - Diagnosis and Management, 4th edition. Roy Patterson, Leslie Grammer, Paul Greenberger, and C. R. Zeiss (eds.), p. 275. J. B. Lippincott Company, 1992.

39. Lieberman P. Comments on the Untoward Effects of Corticosteroids on the Musculoskeletal System. (editorial) Journal of Asthma, 29 (6), 363-368, 1992.

40. Reisman RE, and Lieberman P, editors. Immunology and Allergy Clinics of North America: Anaphylaxis and Anaphylactoid Reactions. W. B. Saunders Company, 12 (3), August 1992.

41. Lieberman P. Anaphylactoid Reactions to Radiocontrast Material. In: Immunology and Allergy Clinics of North America: Anaphylaxis and Anaphylactoid Reactions. Reisman RE, and Lieberman P (eds.), W. B. Saunders Company, 12 (3) pp. 649-670, August 1992.

42. Lieberman P, and Lemanske R (eds.). Asthma Edition: Abstract-A-Card System. Physicians Postgraduate Press, Inc. 1(1-4), May 1991-May 1992.

43. Lieberman P. Using Drugs and Other Measures to Treat Rhinitis. Contemporary Internal Medicine, 47, November-December, 1992.

44. Lieberman P. A Restauranteur with a One Year Itch. Clinical Cases . In: Allergic Diseases, Vol. 2, No. 1, p. 5-8, Spring 1993.

45. Lieberman P. The Classic Antihistamines: Why Do They Work? Allergies in Otolaryngology, (Cliggott Communications, Greenwich, CT), 1(2):6-9, July 1993.

46. Lieberman P. Antihistamine-Induced Sedation: Patients May Not Recognize Impairment. Allergies in Otolaryngology, (Cliggott Communications, Greenwich, CT), 1(3):6-8, October 1993.

47. Lieberman P. Two Nonsedating Antihistamines: How Do They Compare? Allergies in Otolaryngology, (Cliggott Communications, Greenwich, CT), (4)7-9, December 1993.

48. Lieberman P. Update on Inflammation and Hyperresponsiveness in Asthma. Journal of Respiratory Disease, 15 (supplement 9):S8-S18, September 1994.

49. Lieberman P. Preventing Fatalities from Anaphylaxis: An Allergist-Immunologist’s Perspective. (Editorial) Allergy Proceedings. Vol 16(3):109-111, (May-June) 1995.

50. Lieberman P. Distinguishing Anaphylaxis from Other Serious Disorders. Journal of Respiratory Disease , 16(4):411-420, April 1995.

51. Lieberman P. Anaphylaxis: Guidelines for Prevention and Management. Journal of Respiratory Disease 16(5):456-462, May 1995.

52. Lieberman P. Allergies in the Garden. Greenthumb 1:16, 1995.

53. Lieberman P. Antihistamines. In: Clinical Immunology, Robert R. Rich (ed), pp. 1968-1979, Mosby, 1995.

54. Winbery SL, and Lieberman P. Anaphylaxis. In: Immunology and Allergy Clinics of North America,
Frank S. Virant, M.D. (ed.), W. B. Saunders Company, 15(3):447-476, August 1995.

55. Lieberman P. Office Management of Anaphylaxis and Anaphylactoid Reactions. Bierman, Pearlman, et al, 1996.

56. Lieberman P. Specific and Idiopathic Anaphylaxis: Pathophysiology and Treatment. Allergy, Asthma and Immunology from Infancy to Adulthood, 3rd Edition, edited by Bierman W, Pearlman D, Shapiro G and Busse W (W.B.Saunders Company, publishers), Section 4, Chapter 21:297-320, 1996.

57. Winbery SL, and Lieberman P. Anaphylaxis and Histamine Antagonists. In: Histamine and H1 Receptor Antagonists in Allergic Disease, Clinical Allergy and Immunology. F. Estelle R. Simons (ed.). Marcel Dekker, Inc., Vol 7:297-327, 1996.

58. Lieberman P. Current Practice of Medicine, Editor. Allergy and Immunology, Section VII, Churchill Livingstone Publishers, 1996.

59. Lieberman P. Rhinitis. In: Current Practice of Medicine, pp. VII5.2–VII5.10, Churchill Livingstone Publishers (Roger Bone, series editor), 1996.

60. Patterson R, and Lieberman P. Idiopathic Anaphylaxis: A Purely Internal Reaction. In: Hospital Practice, Vol. 31, No. 7, pp. 47–66, McGraw Hill Publishers, July 15, 1996.

61. Lieberman P. Anaphylaxis and Anaphylactoid Reactions, Current Views, Inc., slide presentation, November 1996.

62. Lieberman P and Blaiss MS. Allergic Diseases of the Eye and Ear. In: Allergic Diseases: Diagnosis and Management, 5th edition, Patterson R, Grammer LC, and Greenberger PA, eds., Philadelphia, Lippincott-Raven, pp. 223-251, 1997.

63. Lieberman P and Anderson J. (Editors) Allergic Diseases: Diagnosis and Treatment, Humana Press, Inc., Totowa, NJ, 1997.

64. Lieberman P. Anaphylaxis. In: Allergic Diseases: Diagnosis and Treatment, pp. 47-64, Humana Press, Inc. publishers, 1997.

65. Lieberman P. Rhinitis. In: Allergic Diseases: Diagnosis and Treatment, pp. 131-149, Humana Press, Inc. publishers, 1997.

66. Lieberman P. Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Asthma and Allergic Disease. In: Allergic Diseases: Diagnosis and Treatment, pp. 315-322, Humana Press, Inc. publishers, 1997.

67. Lieberman P. Anticholinergic Agents. In: Allergic Diseases: Diagnosis and Treatment, pp. 323-330, Humana Press, Inc. publishers, 1997.

68. Kemp SF and Lieberman P. Inhibitors of Angiotensin II: Potential Hazards for Patients at Risk for Anaphylaxis? In: Annals of Allergy, Asthma and Immunology, Volume 78(6):527-529, June 1997.

69. Lieberman P. Anaphylaxis, Medscape Respiratory Care 1(7), 1997. Online journal, edited by C. Warren Bierman, M.D. (http://medscape.com, 1997.)

70. Carter PM, Heinly TL, Yates SW and Lieberman PL. Asthma: The Irreversible Airways Disease. Journal of Investigative Allergology Clinical Immunology, Vol. 7(6):566-571, November-December 1997.

71. Kemp SF, Lieberman P. Inhibitors of Angiotensin II: Potential Hazards for Patients at Risk for Anaphylaxis - Guest Editorial. Annals of Allergy, Asthma and Immunology, Vol. 78(6):527-529, June 1997.

72. Winbery SL and Lieberman P. Anaphylaxis and serum sickness. In: Conn’s Current Therapy (edited by Robert E. Rakel, W. B. Saunders Company), 741-746, 1997.

73. Lieberman P. Anaphylaxis and Anaphylactoid Reactions. In Allergy: Principles and Practice, 5th Edition, edited by Middleton, Ellis, Yunginger, Reed, Adkinson and Busse (Mosby-Year Book, Inc., St. Louis, Missouri), Volume II, Section E, Chapter 77:pp 1079-1092, 1998.

74. Lieberman P. Section editor, Allergy & Immunology. Current Practice of Medicine, (published by Current Medicine, Inc, Philadelphia, PA) Volume 1, Number 1, September 1998.

75. Lieberman P. Rhinitis. In: Current Practice of Medicine, Allergy & Immunology, section editors Lillington and Lieberman, editor-in-chief Fitzgerald FT, (Current Medicine, Inc) Volume 1, Number 1, Chapter 14, pp 115-124, September 1998.

76. Marshall GD and Lieberman P. Anaphylactoid Reactions to Radiocontrast Agents. In: Immunology and Allergy Clinics of North America, Drug Hypersensitivity, guest editor, Stephen Tilles, Vol 18, No. 4:pp.
799-807, November 1998.

77. Lieberman P. Anaphylaxis. In: Current Review of Allergic Diseases, edited by Michael Kaliner
(Current Medicine, Inc.), Chapter 13:pp. 133-143, 1998.

78. Lieberman P. Allergy & Immunology. In: Atlas of Internal Medicine (Current Medicine, Inc., Philadelphia), Eugene Braunwald, Editor-in-Chief, Chapter 6, pp. 6.2-7.49, 1998.

79. Lieberman P. Contributor: How To Outsmart Your Allergies, published by HealthPOINTS, Feeling Fine Company, 13160 Mindanao Way, Suite 270, Marina del Rey, CA 90292, in collaboration with Asthma and Allergy Foundation of America, (Art Ulene, M.D., lead author), 1998.

80. Lieberman P. Contributor, The Diagnosis and Management of Anaphylaxis (parameters of the Joint Task Force). In: Journal of Allergy and Clinical Immunology, June 1998.

81. Lieberman P. Management of Allergic Rhinitis with a Combination Antihistamine/Anti-Inflammatory Agent. Journal of Allergy and Clinical Immunology, Volume 103(3 Pt2):S400-404, March 1999.

82. Heinly T, Lieberman P, and Blaiss M. Mediastinal Neurilemmoma Masquerading as Asthma: A Case Report. Southeastern Allergy and Immunology Meeting, White Sulfur Springs, November 1998 (presentation).

83. Chowdhury B and Lieberman P. Drug Allergens, Haptens and Anaphylatoxins. In: Allergens and Allergen Immunotherapy. Clinical Allergy & Immunology No. 12, 2nd Edition, ed. Richard F. Lockey;
Samuel C. Bukantz, series ed. Michael Kaliner (Marcel Dekker, Inc.), Chapter 16, pp 273-296, 1999.

84. Lieberman P. Understanding Asthma. University Press of Mississippi, 1999.

85. Lieberman P. Consultant: Adkinson NF Jr. Allergy and Immunology. In: Ladenson PW, ed. The Consultation Guide. Baltimore: Lippincott Williams and Wilkins, 1999:1-29.

86. Lieberman P. Anaphylaxis: How to Quickly Narrow the Differential Diagnosis, Journal of Respiratory Disease, 1999;20(3):221-231 (Part one of a two-part series).

87. Lieberman P. Allergic Disease Research. In: Current Drugs Ltd. Weekly Highlights, Week 10, 1999:18-22.

88. Lieberman P. Rhinitis. In: Expert Guide to Allergy and Immunology (American College of Physicians, Philadelphia, P A.), ed. R. G. Slavin and R. E. Reisman, 1999:23-40.

89. Lieberman P. Anaphylaxis: Tips on Prevention and Management, Journal of Respiratory Disease, 1999;20(4):309-316 (Part two of a two-part series).

90. Lieberman P. American Academy of Asthma, Allergy and Immunology - 55th Annual Meeting. In: IDrugs, 1999(2):405-409.

91. Lieberman P and Siegle RL. Reactions to Radiocontrast Material. Anaphylactoid Events in Radiology. Humana Press, Inc. publishers, Clinical Reviews in Allergy and Immunology 1999; 17(4):469-496.

92. Lieberman P. Section co-editor with Glen A. Lillington, M.D., Current Medicine Inc. Philadelphia, Pennsylvania publishers. Current Practice of Medicine, Volume 2, Number9, September 1999.

93. Lieberman P. Rhinitis. In: Current Practice of Medicine, Allergy & Immunology, section editors Lillington and Lieberman, editor-in-chief Antonio M. Gotto Jr., Volume 2, Number 9, Chapter 295, pp 1755-1767, September 1999.

94. Lieberman P. Is it a Cold or an Allergy. In: Wellness Guide, 4, 14-21, 1999.

95. Heinly TL and Lieberman P. Preparation and Mixing of Aeroallergen Vaccines. In: Immunology and Allergy Clinics of North America - Immunotherapy: A Practical Review and Guide, W. B. Saunders Company publishers; edited by Dennis Ledford and Richard Lockey (guest editors), 20:(3):527-532, August 2000.

96. Heinly TL and Lieberman P. Anaphylaxis in Pregnancy. Immunology and Allergy Clinics of North America, Volume 20 (4), 831-838, 2000.

97. Winbery SL and Lieberman P. Anaphylaxis and Histamine Antagonists, accepted for publication in Histamine and H1 Receptor Antagonists in Allergic Disease; edited by Simons FER - Clinical Allergy and Immunology Series, published by Marcel Dekker, Inc., New York - 11:297-327, 2000.

98. Marshall GD and Lieberman PL. Determining Allergic Versus Non-Allergic Drug Reactions. In: Diagnostic Testing of Allergic Diseases; edited by Kemp SF and Lockey RF, published by Marcel Dekker, Inc., New York, Clin Allergy Immunol, Volume 15:217-232, 2000.

99. Pongdee T, Blaiss MS, and Lieberman P. Peak Flow Measurements of Nasal Airway Resistance (presented at the American College of Allergy, Asthma, and Immunology meeting, November 1999. Abstract). Annals of Allergy, Asthma, and Immunology.

100. Settipane R and Lieberman P. Update on Non-allergic Rhinitis. Resident and Staff Physician , 2000 .

101. Lieberman P. Review of AAAAI New Drug Presentations. In: Current Opinion in Anti-Inflammatory and immunomodulatory Investigational Drugs, editors William Hagmann and Roger McMillan (issue editors David Howat and Mariano Elices), Volume 2, pp.153-159, 2000.

102. Lieberman P. A Pathophysiologic Link Between Allergic Rhinitis and Asthma. In: Pediatric Annals, edited by Ricardo Z. Vinuya, Volume 29, Number 7, pp. 405-410, 2000.

103. Lieberman P. Antihistamines. American Academy of Asthma, Allergy and Immunology - 56th Annual Meeting, Anti-Inflammatory Drugs. In: IDrugs 3(6):615-620, 2000.

104. Lieberman P. Antihistamines. In: Allergic Diseases: Diagnosis and Treatment, 2nd edition, Phil Lieberman and John Anderson editors, Humana Press, Totowa, NJ, pp. 323-335, 2000.

105. Lieberman P and Anderson J. (Editors) Allergic Diseases: Diagnosis and Treatment, Humana Press, Inc., Totowa, NJ, 2nd edition, 2000.

106. Lieberman P. Comments on Sinusitis. In: Medical Crossfire, 2(8):21-22, 2000.

107. Lieberman P. The Quest to Define Asthma. In: Coping, pp. 2-3, May-June 2000.

108. Lieberman P. Airway Remodeling and Inflammation. Allergy and Clinical Immunology (publishers Hogrefe and Huber) 65:67 Supplement No. 1, 2000.

109. Graham M, McPherson H and Lieberman P. Skin Testing in the Evaluation of Hymenoptera and Drug Allergy. In: Immunology and Allergy Clinics of North America, 21:301-320, 2001.

110. Lieberman P. Relationship Between Upper Airway Disease and Asthma. In: Resident and Staff Physician, Volume 47, Number 3, page 1-4, March 2001.

111. Lieberman P, Calhoun W, Panettieri R, Peters S, and Rennard S. Asthma and Irreversible Lung Disease, Remodeling - Fact or Fiction? Medical Crossfire, 3(3):31-43, 2001.

112. Lieberman P. New Drugs. Current Drugs Ltd, pages 46-48, April 2001.

113. Lieberman P. Rhinitis. In: Best Practice of Medicine, Internet (http://praxis.md), New York, Praxis Press, May 2001.

114. Lieberman P. Editor - Allergy and Immunology Section. In: Best Practice of Medicine, Internet (http://praxis.md), New York, Praxis Press, May 2001.

115. Settipane RA, Lieberman P. Update on Nonallergic Rhinitis. Annals of Allergy, Asthma and Immunology, Volume 86(5):494-507; quiz 507-508, May 2001.

116. Lieberman P. Antihistamines. In: Clinical Immunology Principles and Practice, 2nd edition, edited by Robert R. Rich, publishers Mosby, Harcourt-International USA, Canada, Australia, pages 109.1-109.11, June 2001.

117. Lieberman P. Oligodeoxynucleotides. In: IDrugs 4(6):636-638, June 2001.

118. Lieberman P. Novel Drugs. In: IDrugs 4(6):639-642, June 2001.

119. Lieberman P: Treatment Update: Non-Allergic Rhinitis. Allergy and Asthma Proceedings, 22:199-204, 2001.

120. Lieberman P. Non-Allergic Rhinitis. In: Conn’s Current Therapy (edited by Robert E. Rakel and Edward Bope), Published by W. B. Saunders Company (Harcourt Health Sciences), Independence Square West, Philadelphia, Pennsylvania, pp. 235-238, 2002.

121. Lieberman P. The Year in Allergy. In: Praxis Post, New York, Praxis Press, 2001.

122. Lieberman P and Stuart Stoloff. Clinician’s Manual on Rhinitis: Both Allergic and Non-Allergic. Science Press Ltd., 34-42 Cleveland Street, London, W1T 4LB, U.K, 2001.

123. Lieberman P, Yates S, and Welk K. Pulmonary Remodeling in Asthma. In: The Journal of Investigational Allergology and Clinical Immunology, 11(4):220-234, 2001.

124. Bochner B, Bratton D, Corren J, Ferguson B, Lemanske R, Lieberman P, Rosenthal M, Shapiro G, Storms W (in alphabetical order). Asthma and Allergic Rhinitis: Connecting Common Pathways and Treatment. Internal Medicine, 23:1-24, 2001.

125. Lieberman P. Unique Clinical Presentations of Anaphylaxis. In: Immunology and Allergy Clinics of North America (edited by Stephen Kemp, M.D.), 21(4):813-827, 2001.

126. Lieberman P. Correlating Rhinitis with its Treatment. In: Current Reviews of Rhinitis (Current Medicine, Inc. publishers), edition one, 145-154, 2001.

127. Kaliner M and Lieberman P. Examination of the Nasal Cavity. In: Current Reviews of Rhinitis (Current Medicine, Inc. publishers), edition one, 7-12, 2001.

128. Lieberman P, and Blaiss MS. Co-editor, Atlas of Allergic Diseases. Current Medicine, Inc., 400 Market Street, Suite 700, Philadelphia, Pennsylvania, 2002.

129. Lieberman P. Immunoglobulin Structure and Function. In: Atlas of Allergic Diseases (Current Medicine, Inc. publishers), 2:13-16, 2002.

130. Rakel RE, Lieberman P, and Hedges H. New Tools for Diagnosing Rhinitis. In: Family Practice Recertification (Supplement), 24(2):1-12, 2002.

131. Heinly T and Lieberman P. Asthma. In: Best Practice of Medicine, Internet (http://praxis.md), New York, Praxis Press, 2002.

132. Heinly T and Lieberman P. Differential Diagnosis of Asthma. In: Asthma, Raymond G. Slavin and Robert E. Reisman, editors (American College of Physicians, Philadelphia), 3:39-50, 2002.

133. Lieberman P and Blaiss MS. Allergic Diseases of the Eye and Ear. In: Patterson’s Allergic Diseases, 6th Edition, Leslie C. Grammar and Paul A. Greenberger, editors (Lippincott Williams & Wilkins, Philadelphia, PA), Chapter 11:195-223, 2002.

134. Lieberman P. Asthma and Allergic Rhinitis Connection. In: The Link, Issue 1, May 2002 (magazine).

135. Lieberman P, Calhoun W, Panettieri R, Peters S, and Rennard S. Airway Remodeling in Asthma. In: Medical Crossfire, Volume 4, May 15, 2002.

136. Winbery SL and Lieberman P. Histamine and Antihistamines in Anaphylaxis. In: Anaphylaxis, edited by Simons FER - published by Marcel Dekker, Inc., New York - 9:287-317, 2002.

137. Lieberman P. Allergy & Immunology. In: Atlas of Internal Medicine, Second Edition (Current Medicine, Inc., Philadelphia), Eugene Braunwald, Editor-in-Chief, Chapter 6:253-277, 2002.

138. Lieberman P. Anaphylactic Reactions During Surgical and Medical Procedures. In: The Journal of Allergy and Clinical Immunology (Natural Rubber Latex Sensitivity), Volume 110:S64-S69, 2002.

139. Lieberman P. Preclinical Evidence of Azelastine Hydrochloride Activity. In: Current Therapeutic Research, 63(9):556-571, 2002.

140. Lieberman P. Evaluation and Management of the Patient with a History of a Previous Episode of Anaphylaxis. Allergy and Clinical Immunology (2002).

141. Lieberman P. Chronic Non-allergic Rhinitis. In: Allergy and Clinical Immunology International, Volume 14, pages 266-273, 2002.

142. Lieberman P. Anaphylaxis and Anaphylactoid Reactions. In: Allergy: Principles and Practice, 6th Edition, edited by Middleton, Adkinson, Yunginger, Busse, Bachner, Holgate, and Simons (Mosby-Year Book, Inc., St. Louis, Missouri), Volume II, pp 1497-1522, 2003.

143. Lieberman P and Settipane RA. Azelastine Nasal Spray: A Review of Pharmacology and Clinical
Efficacy in Allergic and Nonallergic Rhinitis. In: Allergy and Asthma Proceedings, 24:95-105, 2003.

144. Lieberman P. Is There an Epidemic of Asthma in the African-American Population of the U.S.? In: Physician’s Q&A, Midsouth Edition, pp. 50-51, 2003 (January/February).

145. Lieberman P. Chronic Nonallergic Rhinitis. Submitted for publication to UpToDate, Rose, BD (Ed), UpToDate, Wellesley, MA, 2003.

146. Lieberman P. Non-Allergic Rhinitis. In: Conn’s Current Therapy (edited by Robert E. Rakel and Edward Bope), Published by Saunders, The Curtis Center (Elsevier Science), Independence Square West, Philadelphia, Pennsylvania, pp. 204-207, 2003.

147. Lew DB and Lieberman P. Lung Remodeling in Asthma. In: Allergy and Clinical Immunology International, Volume 15, pp. 4-10, 2003.

148. Lieberman P. Use of Epinephrine in the Treatment of Anaphylaxis. In: Current Opinion in Allergy and Clinical Immunology, 3:313-318, 2003.

149. Hernandez-Trujillo VP, Lieberman PL, and Chowdhury BA. Drug Allergens, Haptens, and
Anaphylotoxins. In: Allergens and Allergen Immunotherapy, 3rd edition, edited by Richard Lockey, Stan Bukantz, and Jean Bousquet. Part of Clinical Allergy and Immunotherapy Series, Executive Director, Michael Kaliner. Publisher Marcel Dekker, pp. 387-419, 2004.

150. Lieberman P. Clinician’s Manual on Anaphylaxis (published by Current Medicine), 2003.

151. Lieberman P. Contributor – Understanding Anaphylaxis: Defining, Identifying and Treating Severe
Allergic Reactions. In: Infectious Diseases in Children, CME sponsored activity (supplement), April 2004.

152. Lieberman P. Biphasic Anaphylaxis. In: Allergy and Clinical Immunology International, Journal
of the World Allergy Organization, Volume 16(6), pp 241-248, November/December 2004.

153. Lieberman P, Kemp S, Oppenheimer J, Lang D, Bernstein I, and Nicklas RA. The Diagnosis and
Management of Anaphylaxis: An Updated Practice Parameter, sponsored by The Joint Task Force on Practice Parameters representing the American Academy of Allergy, Asthma, and Immunology, the American College of Allergy, Asthma, and Immunology, and the Joint Council of Allergy, Asthma, and Immunology. Journal of Allergy, Asthma, and Immunology 2005; 115(3):S483-S523.

154. Sampson HA, Munoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, Decker WW, Furlong TJ, Galli SJ, Golden DB, Gruchalla RS, Harlor AD, Hepner DL, Howarth M, Kaplan AP, Levy JH, Lewis LM, Lieberman PL, Metcalfe DD, Murphy R, Pollart SM, Pumphrey RS, Rosenwasser LJ, Simons FE, Wood JP, and Camargo CA Jr. Symposium on the Definition and Management of Anaphylaxis: Summary Report. Journal of Allergy and Clinical Immunology, 115(3):584-592, March 2005.

155. Lieberman P, Kemp S, Oppenheimer J, Lang D, Bernstein IL, and Nicklas RA. Beta-blockers and anaphylaxis: are the risks overstated? Journal of Allergy and Clinical Immunology 2005; 116:931-935.

156. Lieberman P. Anaphylaxis. In: Medical Clinics of North America, (guest editor Anthony Montanaro). Publisher Elsevier, Saunders, January 2006; Volume 90, Number 1, pages 77-95.

157. Dey JH, Horak F, Briscoe M, Canonica G, Fineman S, Krug N, Leynadier F, Lieberman P, Quirce S, Takenak H, and Van Cauwenberge P. The Role of Allergen Challenge Chambers in the Evaluation of Anti-Allergic Medication: An International Consensus Paper. Clinical and Experimental Allergy Reviews 2006; 6:31-59.

158. Waikart L and Lieberman P. Non-Allergic Rhinitis. In: Conn’s Current Therapy, edited by Rakel and Bope, publisher Saunders (Elsevier), John Kennedy Boulevard, Philadelphia, PA, 2006; pages 258-263.

159. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SG, Camargo CA Jr, Cydulka R, Galli SJ, Gidudy J, Gruchalla RS, Harlor AD Jr, Hepner DL, Lewis LM, Lieberman P, Metcalfe DD, O’Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, and Decker WW. Second Symposium on the Definition and Management of Anaphylaxis: Summary Report – Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. Journal of Allergy and Clinical Immunology, Volume 117(2), page 391-397, February 2006; and Ann Emerg 47(4):373-380, April 2006.

160. Lieberman P, Kaliner M, Lockey R, and Simons FER. Anaphylaxis and the American Academy of Allergy, Asthma, and Immunology. Journal of Allergy and Clinical Immunology, Volume 117(2), page 478-482, February 2006.

161. Lieberman P. Translating Science to Community Action. In: Annals of Allergy, Asthma, and Immunology, 96(3):381-382, March 2006.

162. Leonard Bieolory, Michael Blaiss, Stanley Fineman, Dennis Ledford, Phil Lieberman, Estelle Simons, David Skoner, and William Storms. “Concerns about intranasal corticosteroids for over-the-counter use: Position Statement of the Joint Task Force of the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology.” Annals of Allergy, Asthma, and Immunology, 2006; 96(4):514-525.

163. Lieberman PL, Camargo C, Simons FER, Jick H, Sheikh A, Bohlke K, and Miller R. Epidemiology of Anaphylaxis: Findings of the ACAAI Epidemiology of Anaphylaxis Working Group. In: Annals of Allergy, Asthma, and Immunology, November 2006, pp 596-602.

164. Lieberman PL. Chronic Nonallergic Rhinitis. In: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA 2006.

165. Waikart L, Kaliner M and Lieberman P. Examination of the Nasal Cavity. In: Current Reviews of Rhinitis, Kaliner, M (ed.) (Current Medicine, Inc., PA publishers), second edition, pp 9-14, 2006.

166. Waikart L and Lieberman P. Appropriate Treatment Choices in the Management of the Symptoms of Rhinitis. In: Current Reviews of Rhinitis, Kaliner, M (ed.) (Current Medicine, Inc., PA publishers), second edition, pp 149-160, 2006.

167. Lieberman P. Allergen Immunology. In: Atlas of Internal Medicine, Eugene Braunwald (ed) (Current Science Ltd., publisher), third edition, pp 255-279, 2007.

168. Varghese M and Lieberman P. The Effects of Repeat Omalizumab Administration on Skin Test Positivity and the Assessment of the Safety of Administration in Patients with Positive Skin Tests for Mouse Antigen. Allergy and Asthma Proceedings, 28(3):320-323, May-June 2007.

169. Lieberman P. Biphasic Anaphylaxis. In: UpToDate, Rose BD (ed), UpToDate, Waltham, MA, 2006.

170. Lieberman P. Chronic Nonallergic Rhinitis. In: UpToDate, Rose BD (ed), UpToDate, Waltham, MA, 2007.

171. Lieberman P. Editor. Anaphylaxis. In: Immunology and Allergy Clinics of North America, Volume 27, No. 2, May 2007. Published by Saunders, an imprint of Elsevier, Inc.

172. Tole J, Lieberman P. Biphasic Anaphylaxis: Review of Incidence, Clinical Predictors, and Observation Recommendations. In: Immunology and Allergy Clinics of North America, Volume 27, No. 2, May 2007, pp 309-326. Published by Saunders, an imprint of Elsevier, Inc.

173. Mitchell G, Hernandez-Trujillo V, and Lieberman P. Allergy. In: Textbook of Family Medicine, edited by Robert Rakel, 7th edition. Published by Saunders, Elsevier 2007, pp 463-477.

174. Lieberman P, Decker W, Camargo CA, O’Connor R, Oppenheimer J, and Simons FER. SAFE. A Multi-Disciplinary Approach to Anaphylaxis Education in the Emergency Department. Annals of Allergy, Asthma, and Immunology, 98:519-523, 2007.

175. Lieberman P. The Unusual Suspects: A Surprise Regarding Reactions to Omalizumab. Allergy and Asthma Proceedings, 28(3):259-261, May-June 2007.

176. Beaty AD, Lieberman PL, and Slavin RG. Seafood Allergy and Risk of Adverse Reactions to Radiocontrast Media: Are Physicians Unwittingly Propagating a Medical Myth? (The American Journal of Medicine, August 2007).

177. Lehman J and Lieberman P. Office Based Management of Allergic Rhinitis in Adults. The AmericanJournal of Medicine, August 2007, 120:659-663.

178. Lieberman P and Anderson J. Allergic Diseases: Diagnosis and Treatment, Third Edition. Humana Press, Totowa, New Jersey, 2007.

179. Hernandez-Trujillo V and Lieberman P. Antihistamines. In: Allergic Diseases: Diagnosis andTreatment, 3rd edition. Phil Lieberman and John Anderson, editors. Humana Press, Totowa, New Jersey, 2007; pages 319-335.

180. Hernandez-Trujillo V, Lieberman J, and Lieberman P. Antihistamines. In: Clinical Immunology Principles and Practice, 3rd edition, edited by Robert R. Rich, publishers Mosby, Harcourt-International USA, Canada, Australia (in press; due late 2007 or early 2008).

181. Lieberman P. Nonallergic Rhinitis. In: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA. Accepted for publication 2008.

182. Lieberman P. Measuring Asthma Control: Sputum Eosinophils, Nitric Oxide, and Other Inflammatory Markers. Allergy and Asthma Proceedings, Volume 28, Number 5, page 510-513, 2007.

183. Lieberman P. (date posted pending 2007) Allergic Remodeling [online]. World Allergy Organization, Allergic Diseases Resource Center. Available from: http://www.worldallergy.org/adrc/.

184. Lieberman P. Automatic epinephrine injectors: a change in perspective from the pulmonologists’ standpoint? In: Pulmonary Perspectives, Chest Physician, page 11, December 2007, volume 2, number 12.

185. Mitchell G, Hernandez-Trujillo V, and Lieberman P. Allergy. In: Textbook of Family Medicine, 2007. Published by Saunders. Editor Rakel, 7th Edition, pages 463-476.

186. Lieberman P. Co-editor (with H. James Wedner), Anaphylaxis and Drug Allergy Section of Current Allergy and Asthma Reports, Volume 8 (1), March 2008, Volume 1, pages 35-63. Published by Current Science.

187. Lieberman P. Clinical Trials Report, Hereditary Angioedema. Anaphylaxis and Drug Allergy Section of Current Allergy and Asthma Reports, Volume 8 (1), March 2008, Volume 1, pages 35-37.

188. Lieberman P. Co-editor, with Dr. James Wedner. Anaphylaxis and Drug Allergy Section. Current Allergy and Asthma Reports 2008; Volume 8 (1), pages 35-63.

189. Lieberman P. Clinical Trial Reports: Treatment of Hereditary Angioedema. Current Allergy and Asthma Reports 2008; Volume 8(1), page 35-36.

190. Lieberman P, Hernandez-Trujillo V, Lieberman J, and Frew A. Antihistamines. In: Clinical Immunology Principles and Practice, Third Edition; editors, Robert R. Rich, et al.; publisher, Mosby (Elsevier); pages 1317-1330, 2008.

191. Lieberman P. Epidemiology of anaphylaxis. Current Opinion in Allergy Clinical Immunology 2008; 8(4):316-320.

192. Khan BQ and Lieberman P. Anaphylaxis in the elderly. In: Aging Health, Volume 4, Number 4, August 2008, pages 377-387.

193. Lieberman P. Section editor on Anaphylaxis. Current Allergy and Asthma Reports; 2008

194. Lieberman P. Anaphylaxis. In: Allergy: Principles and Practice, Edition 7, edited by Atkinson F, Bochner B, Busse W, Holgate S, Lemanske R, and Simons FER (Publisher Mosby, an affiliate of Elsevier, Inc.), 2009; 1027-1051.

195. Lieberman P: Is This a Death Knell for Anti-Interleukin-5 Therapy in Asthma? In: Current Allergy and Asthma Reports 2009; 9(1):41-42.

196. Lieberman P. Allergy Immunology. Atlas of Internal Medicine, 3rd edition, edited by Eugene Braunwald, published by Current Medicine LLC, 2009; pages 255-274.

197. Lieberman P. A case for switching to HFA-BDT: a review of patients with poorly controlled symptoms. In: Reviews and Trends in Respiratory Medicine 2009; Volume 1, Number 4; pages 4-9.

198. Lieberman P. The peripheral eosinophil count. World Allergy Organization Journal, online publication, Volume 6, Issue 6, June 3, 2009 (http://www.worldallergy.org/clinical_allergy_tips/tips_lieberman.pdf).

199. Lieberman P. Intranasal antihistamines for allergic rhinitis: mechanisms of action. Allergy and Asthma Proceedings, accepted for publication June 7, 2009 (in press).

200. Lieberman P. The Role of antihistamines in treatment of vasomotor rhinitis. Submitted to the Journal of the World Allergy Organization, June 8, 2009 (in press).

201. Kaliner M, Baraniuk J, Benninger M, Bernstein J, Lieberman P, Meltzer O, Neclario R, Settipane R. Consensus definition of nonallergic rhinopathy. World Allergy Organization Journal, online publication, Volume 6, Issue 6, 2009.

202. Jacobs R, Lieberman P, Kent E, Silvey M, Locantore N, and Philpot, EE. Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment. Allergy Asthma Proceedings 2009; 30:120-127.

203. Simons FER, Lieberman P, Read EJ, and Edwards ES. Hazards of unintentional injection of epinephrine from autoinjectors: a systematic review. Annals of Allergy, Asthma, and Immunology 2009; 102:282-287.

204. Lieberman P. Clinical aspects and diagnosis of anaphylaxis. In: Allergy Frontiers: Diagnostics and Health Economics, 2009; Volume 4, Pages 319-335. Published by Springer, edited by Pawankar R, Rosenwasser L, and Holgate S.

205. Lieberman P. Intranasal antihistamines for allergic rhinitis: mechanism of action. Allergy and Asthma Proceedings 2009; 30(4):345-348.

206. Lieberman P. The role of antihistamines in the treatment of vasomotor rhinitis. World Allergy Organization Journal 2009 (August); 2(8):156-161.

207. Lieberman P. Histamine, antihistamines, and the central nervous system. Allergy and Asthma Proceedings, September-October, 2009; 30(5):482-486.

208. Lieberman P, Kemp S, Oppenheimer J, Lang D, Bernstein I, and Nicklas RA. The Diagnosis and Management of Anaphylaxis: An Updated Practice Parameter, sponsored by The Joint Task Force on Practice Parameters representing the American Academy of Allergy, Asthma, and Immunology, the American College of Allergy, Asthma, and Immunology, and the Joint Council of Allergy, Asthma, and Immunology. Submitted for publication, Journal of Allergy, Asthma, and Immunology 2009.

209. Lieberman P. Management of anaphylaxis. Allergy Frontiers: Therapy and Prevention, 2010; Volume 5 (edited by Pawankar, Holgate, and Rosenwasser; published by Springer), pages 311-325.

210. Simons FER, Lieberman P, Reid E, and Edwards E. Hazards of unintentional injection of epinephrine from autoinjectors: a systematic review. Annals of Allergy, Asthma and Immunology 2009; 102:282-287.

211. Daher N and Lieberman P. Immunosuppression medication as an approach to treat chronic idiopathic urticaria in children. Current Allergy and Asthma Reports 2010 (January); Volume 10, Number 7; published online prior to print, DOI:10.1007/S11882-009-0084-4 (two pages).

212. Daher N and Lieberman P. Immunosuppression medication as an approach to treat chronic idiopathic urticaria in children: a clinical trial report. Current Allergy and Asthma Reports 2010; Volume 10, Number 1; pages 1-2.

213. Lieberman P, Mahr T, Ratner P, Pattanaik D. Advances in the treatment of adults and young children with allergic rhinitis. Medscape CME, Allergy and Clinical Immunology, published online 2/8/2010.

214. Pattanaik D and Lieberman P. Vasomotor Rhinitis. Current Allergy and Asthma Reports 2010; 10(2):84-91.

215. Lieberman P, Nicholas R, Kemp S, Oppenheimer J, et al. The Diagnosis and Management of Anaphylaxis: An Updated Practice Parameter. Accepted for publication, June 12, 2010.

RESEARCH PAPERS

1. Lieberman P, Ricks J, Chakrin L, Wardell JR Jr, and Patterson R. Immunoglobulins in Respiratory
Secretions Obtained From the Canine Tracheal Pouch. Proc. Soc. Exptl. Biol. Med. 135(3):713-716, 1970.

2. Lieberman P, Patterson R, Metz R, and Ucena G. Allergic Reactions to Insulin. JAMA 215(7):1106-1112, 1971.

3. Lieberman P, Patterson R, Petersen V, Chakrin L, Wardell JR, and Ricks J. Effect of Antigen Variation
on Production of Antibody in Canine Tracheal Pouch. Journal of Immunology, 107(5):1349-1356, 1971.

4. Lieberman P, Patterson R, and Kunske R. Complications of Long-Term Steroid Therapy for Asthma.
Journal of Allergy and Clinical Immunology, 49(6):329-336, 1972.

5. Lieberman P, Berlin B, Metzger J, and Patterson R. Production of Antibody in the Canine Tracheal
Pouch after Local and Systemic Influenza Immunization. Journal of Immunology, 109(4):864-869, 1972.

6. Harwell W, Patterson J, Lieberman P, and Beachey E. Platelet Aggregation in Atopic and Normal
Subjects. Journal of Allergy and Clinical Immunology, 51:274, 1973.

7. Shereff R, Harwell W, Lieberman P, Rosenberg W, and Robinson H. Effect of Beta Adrenergic
Stimulation and Blockade on Immediate Hypersensitivity Skin Test Reactions. Journal of Allergy and Clinical Immunology, 52(6):328-333, 1973.

8. Lieberman P, Crawford L, Bjelland J, Connell B, and Rice M. Controlled Study of the Cytotoxic
Food Test. JAMA, 231(7):728-730, 1975.

9. Kitabchi AE, Lamkin N Jr, Lieberman P, Ayyagari V, and Baskin F. Allergic Response to Glucagon
Injection ass a Result of Insulin Contamination. Journal of Clinical Endocrinology and Metabolism, 41:863, 1975.

10. Stimpson PG, Paty JG, Hudson T, and Lieberman P. Delayed Hypersensitivity Skin Testing for
Assessing Anergy in the Mid-South. Southern Medical Journal, 69(4):424-426, 1976.

11. Siegle RL, and Lieberman P. Measurement of Histamine, Complement, and Immune Complexes
During Patient Reactions to Iodinated Contrast Material. Investigative Radiology, 11(2):98-101, 1976.

12. Hashimoto K, Lieberman P, and Lamkin N Jr. Angiokeratoma Corporis Diffusum. Archives of
Dermatology. 112:1416, 1976.

13. Lamkin N Jr, Lieberman P, Shereff R, Rosenberg EW, and Robinson H. Effect of Beta Adrenergic
Stimulation and Blockade on Cutaneous Reactivity to Histamine. Journal of Allergy and Clinical Immunology, 57(5):449-453, 1976.

14. Thomas JW, Jenkins G, Cox C, and Lieberman P. Defective Cell Mediated Immunity in Carcinoma
of the Prostate. Investigative Urology, 14:72, 1976.

15. Lamkin Nelson, Lieberman Phil, Hashimoto Ken, Morohashi Masaaki, and Sullivan Pete. Clinical
Conference: Allergic Reactions to Insulin. Journal of Allergy and Clinical Immunology,
58(1 Pt 2):213-223, 1976.

16. Lieberman Phil, Siegle Robert L, Kaplan Robert J, and Hashimoto Ken. Chronic Urticaria and
Intermittent Anaphylaxis: Reactions to Iophendylate. JAMA, 236(13):1495-1497, 1976.

17. Lieberman PL, Rice MC, and Mallette JE Jr. Studies of Urticaria and Acute Serum Sickness with the
Clq Precipitin Test. Archives of Internal Medicine, 137(4):440-442, 1977.

18. Ganier LM, and Lieberman PL. Infantile Agammaglobulinemia and Immediate Hypersensitivity
to Penicillin. JAMA, 237:1852-1853, 1977.

19. Ganier LM, Lieberman PL, and George SL. Comparison of Results of Skin Testing with Stock
Antigen Mixtures versus Individual Antigens. Submitted for publication, 1977.

20. Daman Lauren, Lieberman Phil, Ganier Mitchell, and Hashimoto Ken. Localized Heat Urticaria.
Journal of Allergy and Clinical Immunology, 61(4):273-278, 1978.

21. Siegle Robert L, and Lieberman Phil. The In Vitro White Cell Response of Atopics to Iodinated
Contrast Material. Submitted for publication, 1978.

22. Siegle Robert L, and Lieberman Phil. A Review of Untoward Reactions to Iodinated Contrast
Material. Journal of Urology, 119(5):581-587, 1978.

23. Lieberman Phil, Siegle Robert L, and Taylor WW Jr. Anaphylactoid Reactions to Iodinated
Contrast Material. Journal of Allergy and Clinical Immunology, 62(3):174-180, 1978.

24. Kelly Joseph, Patterson Roy, Lieberman Phillip, Mathison David A, and Stevenson Donald D.
Radiographic Contrast Media Studies in High-Risk Patients. Journal of Allergy and Clinical Immunology, 62(3):181-184, 1978.

25. Lieberman Phil, and Siegle Robert L. Complement Activation Following Intravenous Contrast
Material Administration. Journal of Allergy and Clinical Immunology, 64(1):13-17, 1979.

26. Ganier Mitchell, and Lieberman Phil. IgE Mediated Hypersensitivity to Pancreatic Extract (PE)
in Parents of Cystic Fibrosis (CF) Children. Clinical Allergy, 9:125-132, 1979.

27. Lieberman P, and Taylor WW Jr. Recurrent Idiopathic Anaphylaxis. Archives of Internal
Medicine, 139(9):1032-1034, 1979.

28. Greenberger Paul, Patterson Roy, Kelly Joseph, Stevenson Donald, Simon Ronald and
Lieberman Phil. Administration of Radiographic Contrast Media in High Risk Patients. Investigative Radiology, 15(6 Suppl):S40-S43, 1980.

29. Ganier Mitchell, Lieberman Phil, Fink Jordan, and Lockwood Dudley G. Humidifier Lung:
An Outbreak in Office Workers. Chest, 77(2):183-187, 1980.

30. Meyer Marvin C, Straughn AB, and Lieberman P. A Multiple-Dose Study of Sustained-
Release Theophylline and Aminophylline. Chest, 78(2):300-303, 1980.

31. Siegle Robert L, Lieberman Phil, Jennings Billy R, and Rice Muriel C. Iodinated Contrast
Material: Studies Relating to Complement Activation, Atopy, Cellular Association, and Antigenicity. Investigative Radiology, 15(6 Suppl):S13-S17, 1980.

32. Hendrix SG, Patterson R, Zeiss CR, Pruzansky JJ, Suszko IM, McQueen RC, Slavin RG,
Miller MP, Lieberman PL and Sheffer AL. A Multi-Institutional Trial of Polymerized Whole Ragweed for Immunotherapy of Ragweed Allergy. Journal Allergy and Clinical Immunology, 66(6):486-494, 1980.

33. Greenberger P, Patterson R, Simon R, Lieberman P, and Wallace W. Pretreatment of High-Risk
Patients Requiring Radiographic Contrast Media Studies. Journal Allergy and Clinical Immunology, 67(3):185-187, 1981.

34. Herrod HG, Miller MM, Crawford LV, Lieberman PL, and Holbert JM. Abnormal Immunologic
Measurements in Asthmatic Children and Adults. Annals Allergy, 47(4):267-272, 1981.

35. Lewis J, Lieberman P, Treadwell G, and Erffmeyer J. Exercise-Induced Urticaria, Angioedema
and Anaphylactoid Episodes. Journal Allergy and Clinical Immunology, 68(6):432-437, 1981.

36. Blaiss MS, Herrod HG, Crawford LV, and Lieberman PL. Beclomethasone Dipropionate Aerosol:
Hematologic and Immunologic Effects. Annals Allergy, 48(4):210-214, 1982.

37. Davis PG, and Lieberman P. Normal Alpha2-Adrenergic Responses in Platelets From Patients
with Asthma. Journal Allergy and Clinical Immunology, 69(1, Part 1):35-38, 1982.

38. Davis P, and Lieberman P. Normal Beta-Adrenergic Responses in Lymphocytes from Patients
with Asthma. Submitted Journal Allergy and Clinical Immunology, 1982.

39. Meyer MC, Straughn AB, Lieberman P, and Jacob J. Serious Bioavailability Problems with a
Generic Prolonged-Release Quinidine Gluconate Product. Journal Clinical Pharmacology 22:131-134, 1982.

40. Erffmeyer JE, McKenna WR, Lieberman PL, Yoo TJ, Taylor W Jr. Efficacy of Phenylephrine-
Phenylpropanolamine in the Treatment of Rhinitis. South Med J 75(5):562-564, May 1982.

41. Lieberman P. Glucocorticosteroid Therapy In Primer on Allergic and Immunologic Diseases:
J Amer Med Assoc, 248:2605, 1982.

42. Rice M, Lieberman P, Siegle R, and Mason J. In Vitro Histamine Release Induced by Radiocontrast
Media and Various Chemical Analogs in Reactor and Control Subjects. Journal Allergy and Clinical Immunology, 72(2):180-186, 1983.

43. Self TH, Brooks JB, Lieberman P, and Ryan MR. The Value of Demonstration and Role of the
Pharmacist in Teaching the Correct Use of Pressurized Bronchodilators. Canadian Medical
Assoc J, 128(2):129-131, 1983.

44. Arbesman C, Bernstein IL, Bierman CW, Bocles JS, Katz R, Lieberman PL, Mattucci K,
Meltzer EO, Middleton E Jr., Noyes J, Pearlman DS, Pence HL, Slavin RG, and Spector SL. Multi-Center Double-Blind Placebo-Controlled Trial of Fluocortin Butyl in Perennial Rhinitis. Journal Allergy and Clinical Immunology, 71(6):597-603, 1983.

45. Siegle RL, Lieberman P, and Rice MC. In Vitro Complement Consumption by Contrast Materials
and Analogues: Reactors versus Nonreactors. Investigative Radiology, 18(4):387-389, 1983.

46. Kaliner M, Dyer J, Merlin S, Shelton A, Greenhill A, Treadwell G, McKenna W, and Lieberman P.
Increased Urine Histamine and Contrast Media Reactions. Investigative Radiology, 19(2):116-118, 1984.

47. Straughn AB, Henderson RP, Lieberman PL, and Self TH. Effect of Rifampin on Theophylline
Disposition. Therapeutic Drug Monitoring, 6(2):153-156, 1984.

48. Erffmeyer JE, Lieberman P, and Siegle R. Anaphylactoid Reactions to Radiocontrast Material.
Journal Allergy and Clinical Immunology, 75:401-410, 1985.

49. Hartley TF, Lieberman PL, Meltzer EO, Noyes JN, Pearlman DS, and Tinkelman DG. Efficacy
and Tolerance of Fluocortin Butyl (FCB) Administered Twice Daily in Adult Patients with Perennial Rhinitis. Journal Allergy and Clinical Immunology, 75(4):501-507, 1985.

50. Irwin RB, Lieberman P, Friedman MM, Kaliner M, Kaplan R, Bale G, Treadwell G, and Yoo TJ.
Mediator Release in Local Heat Urticaria: Protection with Combined H1 and H2 Antagonists. Journal Allergy and Clinical Immunology, 76(1):35-39, 1985.

51. Cohen R, Grant W, Lieberman P, Potter W, Golden E, Crawford L, Herrod H, and Yoo TJ.
The Use of Methacholine Inhalation, Methacholine Skin Testing, Distilled Water Inhalation Challenge and Eosinophil Counts in the Evaluation of Patients Presenting with Cough and/or Nonwheezing Dyspnea. Annals Allergy, 56(4):308-312, 1986.

52. Younger RE, Herrod HG, Lieberman PL, and Crawford LV. Reduced Production of Histamine
Release Enhancing Factor (HREF) by Cord Blood Mononuclear Cells. Pediatric Research. Submitted 1985.

53. Younger RE, Herrod HG, Lieberman PL, Trouy RL, and Crawford LV. Characteristics of
Diatrizoate-Induced Basophil Histamine Release. Journal Allergy and Clinical Immunology,
77(No. 1, Part 1):94-100, 1986.

54. Younger RE, Herrod HG, Lieberman PL, Valenske, WR, Trouy RL, and Crawford LV.
Characterization of Mononuclear Cell-Derived Histamine Release Enhancing Factor. Journal Allergy and Clinical Immunology, 80(4):547-557, 1987.

55. Betlach CJ, Straughn AB, Meyer MC, Lieberman PL, Micle T, and Gonzalez MA. The Absorption
of Theophylline from Theo-Dur(R) Sprinkle Dosed One-Half Hour Before a Meal. Submitted Journal Allergy and Clinical Immunology, 1987.

56. Siegle RL, and Lieberman P. Histamine Release, Complement Activation and Immune Mechanisms
Associated with the Use of Iodinated Contrast Material. In: Contrast Media: Biologic Effects and Clinical Application. Vol I. (Zaheer Parvez, Rogelio Moncada, Milos Sovak, eds.) CRC Press, Inc. (Boca Raton, FL), pp 151-162, 1987.

57. Orgel HA, Meltzer EO, Bierman CW, Bronsky E, Connell JT, Lieberman PL, Nathan R, Pearlman DS,
Pence HL, Slavin RG, et al. Intranasal Fluocortin Butyl in Patients with Perennial Rhinitis: A
12-Month Efficacy and Safety Study Including Nasal Biopsy. Journal Allergy and Clinical
Immunology, 88(2):257-264, August 1991.

58. Sheffer AL, Lieberman PL, Aaronson DW, Anderson JA, Kaplan AP, Pierson WE, Ellis EF,
Lichtenstein LM, Lockey RF, Salvaggio JE, et al. Measurement of Circulating IgG and IgE
Food-Immune Complexes. Journal of Allergy and Clinical Immunology, 81(4):758-760, 1988.

59. Marshall G, and Lieberman P. Comparison of Three Pretreatment Protocols to Prevent
Anaphylactoid Reactions to Radiocontrast Media. Annals of Allergy, 67(1):70-74, July 1991.

60. Betlach CJ, Straughn AB, Meyer MC, Bialer M, Vashi VI, Lieberman P, and Gonzales MA. The
Effect of Raising Gastric pH with Ranitidine on the Absorption and Elimination of Theophylline from a Sustained-Release Theophylline Tablet. Pharmaceutical Research, accepted for publication, 1991.

61. Lockey R, Wasserman ST, Altman LC, Whitcomb NJ, and Lieberman P. A Placebo-controlled
Comparison of Cetirizine Terfenadine in Seasonal Allergic rhinitis, 1991.

62. Arlian LG, Bernstein D, Bernstein IL, Friedman S, Grant A, Lieberman P, Lopez M, Metzger J,
Platts-Mills T, Schatz M, Spector S, Wasserman SI, and Zeiger RS. Prevalence of Dust Mites in the Homes of People Living in Eight Different Geographic Areas of the United States. Journal Allergy and Clinical Immunology, 90(3 Pt 1):292-300, September 1992.

63. Lockey R, Findley S, Mitchell D, Woehler T, Lieberman P, and Nicodemus C. Effects of
Cetirizine versus Terfenadine in Seasonal Allergic Rhinitis. Annals of Allergy, 70(4):311-315, April 1993.

64. Dykewicz MS, Kim HW, Orfan N, Yoo TJ, and Lieberman P. Immunologic Analysis of
Anaphylaxis to Protamine Component in Neutral Protamine Hagedorn Human Insulin. Journal Allergy and Clinical Immunology, 93(1 Pt 1)117:125, January 1994.

65. Kemp SF, Lockey RF, Wolf BL, and Lieberman P. Anaphylaxis, A Review of 266 Cases. Archives
of Internal Medicine, Vol. 155(16):1749-1754, September 1995.

66. Berger WE, Fineman SM, Lieberman P, Miles RM, and the Rhinitis Study Group. Double-Blind Trials of
Azelastine Nasal Spray Monotherapy Versus Combination Therapy with Loratadine Tablets and
Beclomethasone Nasal Spray in Patients with Seasonal Allergic Rhinitis. Annals of Allergy, Asthma, &
Immunology, 82(6):535-541, June 1999.

67. Banov C, Lieberman P. Vasomotor Rhinitis Study Groups: Efficacy of azelastine nasal spray in the
treatment of vasomotor (perennial nonallergic) rhinitis. Annals of Allergy, Asthma, & Immunology,
86(1):28-35, January 2001.

68. Lieberman P, Rakel R, Hedges H, Kuritzky L, Ledgerwood G, Suillace S, and Stoloff S. Quantifying
the Incidence of Mixed Rhinitis with a New Patient Screening Tool. Today’s Therapeutic Trends
20:221-232, 2002.

69. Lieberman P, Kaliner M, and Wheeler WJ. Open-Label Evaluation of Azelastine Nasal Spray in Patients With Seasonal Allergic Rhinitis and Nonallergic Vasomotor Rhinitis. Current Medical Research and
Opinions, 21(4):611-618, 2005.

70. Webb L and Lieberman P. Anaphylaxis: A Review of 601 Cases. Annals of Allergy, Asthma, and Immunology, July 2006; 97(1):39-43.

71. Lieberman P, Decker W, Camargo C, O’Connor R, Oppenheimer J, and Simons S. SAFE: A Multidisciplinary Approach to Anaphylaxis Education in the Emergency Department. Annals of Allergy, Asthma and Immunology (accepted for publication February 7, 2007).

72. Camargo CA Jr., Clark S, Kaplan MS, Lieberman P, Wood RA. Regional Differences in EpiPen Prescriptions in the United States: The Potential Role of Vitamin D. Journal of Allergy and Clinical
Immunology, 2007; 120:131-136.

73. Beaty AD, Lieberman P, and Slavin, RG. Seafood Allergy and Radiocontrast Media: Are Physicians Propagating a Myth? American Journal of Medicine 2008; 121(2):158. e1-158. e4 (published online
prior to print).

74. Jacobs R, Lieberman P, Kent E, Silvey M, Locantore N, and Philpot E. Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid therapy. Allergy and Asthma
Proceedings (accepted for publication 2008).

75. Simons FER, Lieberman PL, Reid E, and Edwards ES. Hazards of unintentional injection of epinephrine from auto-injectors: a systematic review. Annals of Allergy, Asthma, and Immunology 2009; 102:282-287.

76. Commins SP, James H, Tran N, Kelly E, Mullins R, Lieberman P, Platts-Mills T. Testing for IgE antibody to the carbohydrate galactose-a-1, 3-galactose in patients with recurrent idiopathic anaphylaxis: How
many cases are we missing? J Allergy Clin Immunol 2010; 125(2):AB119 (Supplement).